The current patent covers a matrix that is useful for treatment of cartilage injuries. The matrix disclosed is resorbable at a controlled rate and contains collagen II either from autologous, allogeneic, or xenogeneic sources. Specific pore sizes and additives are claimed.
The patent is useful for parties seeking methods of introducing cells or growth factors to accelerate cartilage healing in a physiological and three dimensional manner.
The patent is especially useful in conjunction with mesenchymal stem cells whether they be bone marrow, fat, or cord blood derived.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.